M C Montes, J A Rueda-Camino, N Rallón, S Nistal-Juncos, R Barba Martín
{"title":"Aging with HIV: A cross-sectional look at comorbidities.","authors":"M C Montes, J A Rueda-Camino, N Rallón, S Nistal-Juncos, R Barba Martín","doi":"10.1016/j.rceng.2025.502310","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People living with HIV (PLHIV) are at increased risk of multimorbidity compared to the general population. The goal of this study is to evaluate the prevalence of non-infectious comorbidities and geriatric syndromes in PLHIV ≥ 50 years old.</p><p><strong>Methods: </strong>A cross-sectional analysis was conducted on a cohort of PLHIV regularly followed at an outpatient clinic in a University Hospital in Spain, focusing on PLHIV aged 50 and above. Participants were categorized by age into ten-year intervals. Crude and standardized prevalence of each comorbidity and its trend across age groups were estimated. The prevalence of multimorbidity (≥2 diseases) was also evaluated. All prevalence were estimated with the exact method.</p><p><strong>Results: </strong>We evaluated 122 PLHIV, of which 25.4% were women and 13% resided in nursing homes. The median time between HIV diagnosis and the last documented visit was 19 (9-29) years. Overall prevalence of multimorbidity was 37% (95% CI 28.4 %-45.6 %), being the most prevalent comorbidities cardiovascular risk factors dyslipidemia (37.7%; 95% CI 29.6 %-46.6 %), hypertension (26.2%; 95% CI: 19.2 %-34.7 %), diabetes mellitus (14.8%; 95% CI: 9.5 %-22.1 %) and non-AIDS defining cancers (15.6%; 95% CI: 10.2 %-23.0 %). The most common geriatric syndromes were fractures/osteoporosis (9.8%; 95% CI: 5.7 %-16.4 %), dementia (8.2%; 95% CI: 4.5-14.4 %) and frailty (8.2%; 95% CI: 4.5-14.4 %). The prevalence of most comorbidities and multimorbidity showed a significantly increasing trend across age groups.</p><p><strong>Conclusions: </strong>PLHIV who are over 50 years of age have a high prevalence of non-infectious comorbidities and geriatric syndromes. Multimorbidity increases with age in this population group.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502310"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rceng.2025.502310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: People living with HIV (PLHIV) are at increased risk of multimorbidity compared to the general population. The goal of this study is to evaluate the prevalence of non-infectious comorbidities and geriatric syndromes in PLHIV ≥ 50 years old.
Methods: A cross-sectional analysis was conducted on a cohort of PLHIV regularly followed at an outpatient clinic in a University Hospital in Spain, focusing on PLHIV aged 50 and above. Participants were categorized by age into ten-year intervals. Crude and standardized prevalence of each comorbidity and its trend across age groups were estimated. The prevalence of multimorbidity (≥2 diseases) was also evaluated. All prevalence were estimated with the exact method.
Results: We evaluated 122 PLHIV, of which 25.4% were women and 13% resided in nursing homes. The median time between HIV diagnosis and the last documented visit was 19 (9-29) years. Overall prevalence of multimorbidity was 37% (95% CI 28.4 %-45.6 %), being the most prevalent comorbidities cardiovascular risk factors dyslipidemia (37.7%; 95% CI 29.6 %-46.6 %), hypertension (26.2%; 95% CI: 19.2 %-34.7 %), diabetes mellitus (14.8%; 95% CI: 9.5 %-22.1 %) and non-AIDS defining cancers (15.6%; 95% CI: 10.2 %-23.0 %). The most common geriatric syndromes were fractures/osteoporosis (9.8%; 95% CI: 5.7 %-16.4 %), dementia (8.2%; 95% CI: 4.5-14.4 %) and frailty (8.2%; 95% CI: 4.5-14.4 %). The prevalence of most comorbidities and multimorbidity showed a significantly increasing trend across age groups.
Conclusions: PLHIV who are over 50 years of age have a high prevalence of non-infectious comorbidities and geriatric syndromes. Multimorbidity increases with age in this population group.